Literature DB >> 18322535

Transient cyclical methylation of promoter DNA.

Sara Kangaspeska1, Brenda Stride, Raphaël Métivier, Maria Polycarpou-Schwarz, David Ibberson, Richard Paul Carmouche, Vladimir Benes, Frank Gannon, George Reid.   

Abstract

Methylation of CpG dinucleotides is generally associated with epigenetic silencing of transcription and is maintained through cellular division. Multiple CpG sequences are rare in mammalian genomes, but frequently occur at the transcriptional start site of active genes, with most clusters of CpGs being hypomethylated. We reported previously that the proximal region of the trefoil factor 1 (TFF1, also known as pS2) and oestrogen receptor alpha (ERalpha) promoters could be partially methylated by treatment with deacetylase inhibitors, suggesting the possibility of dynamic changes in DNA methylation. Here we show that cyclical methylation and demethylation of CpG dinucleotides, with a periodicity of around 100 min, is characteristic for five selected promoters, including the oestrogen (E2)-responsive pS2 gene, in human cells. When the pS2 gene is actively transcribed, DNA methylation occurs after the cyclical occupancy of ERalpha and RNA polymerase II (polII). Moreover, we report conditions that provoke methylation cycling of the pS2 promoter in cell lines in which pS2 expression is quiescent and the proximal promoter is methylated. This coincides with a low-level re-expression of ERalpha and of pS2 transcripts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322535     DOI: 10.1038/nature06640

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  257 in total

1.  Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis.

Authors:  Ozren Bogdanovic; Steven W Long; Simon J van Heeringen; Arie B Brinkman; Jose Luis Gómez-Skarmeta; Hendrik G Stunnenberg; Peter L Jones; Gert Jan C Veenstra
Journal:  Genome Res       Date:  2011-06-02       Impact factor: 9.043

2.  Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability.

Authors:  Daniel Cortázar; Christophe Kunz; Jim Selfridge; Teresa Lettieri; Yusuke Saito; Eilidh MacDougall; Annika Wirz; David Schuermann; Angelika L Jacobs; Fredy Siegrist; Roland Steinacher; Josef Jiricny; Adrian Bird; Primo Schär
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

3.  DNA methylation and memory formation.

Authors:  Jeremy J Day; J David Sweatt
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

Review 4.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 5.  Understanding transgenerational epigenetic inheritance via the gametes in mammals.

Authors:  Lucia Daxinger; Emma Whitelaw
Journal:  Nat Rev Genet       Date:  2012-01-31       Impact factor: 53.242

6.  Masculine epigenetic sex marks of the CYP19A1/aromatase promoter in genetically male chicken embryonic gonads are resistant to estrogen-induced phenotypic sex conversion.

Authors:  Haley L Ellis; Keiko Shioda; Noël F Rosenthal; Kathryn R Coser; Toshi Shioda
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

Review 7.  Epigenetic programming and risk: the birthplace of cardiovascular disease?

Authors:  Maria Cristina Vinci; Gianluca Polvani; Maurizio Pesce
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 8.  CpG methylation in neurons: message, memory, or mask?

Authors:  Rajiv P Sharma; David P Gavin; Dennis R Grayson
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

Review 9.  Methods in DNA methylation profiling.

Authors:  Tao Zuo; Benjamin Tycko; Ta-Ming Liu; Juey-Jen L Lin; Tim H-M Huang
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

Review 10.  Molecular brake pad hypothesis: pulling off the brakes for emotional memory.

Authors:  Annie Vogel-Ciernia; Marcelo A Wood
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.